Currently, there are 415.88M common shares owned by the public and among those 405.29M shares have been available to trade.
The company’s stock has a 5-day price change of -7.04% and 11.01% over the past three months. GNW shares are trading 17.67% year to date (YTD), with the 12-month market performance up to 3.86% higher. It has a 12-month low price of $5.99 and touched a high of $8.08 over the same period. GNW has an average intraday trading volume of 7.42 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -4.91%, 0.20%, and 2.74% respectively.
Institutional ownership of Genworth Financial Inc (NYSE: GNW) shares accounts for 87.47% of the company’s 415.88M shares outstanding.
It has a market capitalization of $3.01B and a beta (3y monthly) value of 1.12. The stock’s trailing 12-month PE ratio is 14.73, while the earnings-per-share (ttm) stands at $0.49. The company has a PEG of 13.90 and the debt-to-equity ratio at 0.17. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.33% over the week and 2.94% over the month.
Analysts forecast that Genworth Financial Inc (GNW) will achieve an EPS of 0.05 for the current quarter, 0.06 for the next quarter and 0.43 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0.05 while analysts give the company a high EPS estimate of 0.05. Comparatively, EPS for the current quarter was 0.28 a year ago. Earnings per share for the fiscal year are expected to decrease by -29.03%, and 18.18% over the next financial year. EPS should grow at an annualized rate of 1.06% over the next five years, compared to -5.65% over the past 5-year period.
Looking at the support for the GNW, a number of firms have released research notes about the stock. Keefe Bruyette stated their Outperform rating for the stock in a research note on June 18, 2025, with the firm’s price target at $9. Compass Point was of a view on May 05, 2016 that the stock is Buy, while Compass Point gave the stock Buy rating on February 08, 2016, issuing a price target of $7.50- $5.50. Goldman on their part issued Neutral rating on November 17, 2015.
